Cargando…

PM308. A phase 3, multicenter randomized double blind placebo controlled study of the opioid receptor antagonist –Odelepran the treatment of alcohol addiction.

Detalles Bibliográficos
Autores principales:	Krupitsky, E., Mukhametshina, E., Samsonov, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616244/ http://dx.doi.org/10.1093/ijnp/pyw041.308

Ejemplares similares

Opioid agonist and antagonist use and the gut microbiota: associations among people in addiction treatment
por: Gicquelais, Rachel E., et al.
Publicado: (2020)

Sodium oxybate for the maintenance of abstinence in alcohol-dependent patients: An international, multicenter, randomized, double-blind, placebo-controlled trial
por: Guiraud, Julien, et al.
Publicado: (2022)

Differences in addictive beliefs in people with psychostimulant addiction and in opioid addicts
por: Yan, Y., et al.
Publicado: (2022)

In this Issue: Opioid Addiction
por: Khan, Omar A., et al.
Publicado: (2017)

Suicide Risk and Addiction: The Impact of Alcohol and Opioid Use Disorders
por: Rizk, Mina M., et al.
Publicado: (2021)

Multicenter, randomized, double‐blinded, placebo‐controlled study of rabacfosadine in dogs with lymphoma
por: Weishaar, Kristen M., et al.
Publicado: (2021)

Efficacy and safety of persimmon leaf formulated with green tea and sophora fruit extracts (BLH308) on hair growth: A randomized, double‐blind, placebo‐controlled clinical trial
por: Ham, Seoyoon, et al.
Publicado: (2023)

Double-blind, placebo-controlled trial of mifepristone on cognition and depression in alcohol dependence
por: Donoghue, Kim, et al.
Publicado: (2020)

Effects of Omeprazole on Sleep Disturbance: Randomized Multicenter Double-Blind Placebo-Controlled Trial
por: Aimi, Masahito, et al.
Publicado: (2014)

A multicenter double-blind, placebo-controlled randomized trial to evaluate the safety and efficacy of bovine colostrum in the treatment of severe alcoholic hepatitis (SAH)
por: Sidhu, S. S., et al.
Publicado: (2023)

PM405. Sodium Benzoate Add-on Treatment for Refractory Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Lin, Chieh-Hsin, et al.
Publicado: (2016)

Effects of a peripherally acting µ-opioid receptor antagonist for the prevention of recurrent acute pancreatitis: study protocol for an investigator-initiated, randomized, placebo-controlled, double-blind clinical trial (PAMORA-RAP trial)
por: Cook, Mathias E., et al.
Publicado: (2023)

Opioids, dopamine, stress, and the addictions
por: Kreek, Mary Jeanne
Publicado: (2007)

Chronic pain, opioids and addiction
por: Salduker, Shaquir
Publicado: (2018)

A randomised, double-blind, placebo-controlled parallel trial of closed-loop infraslow brain training in food addiction
por: Leong, Sook Ling, et al.
Publicado: (2018)

Rationale and design of a multicenter, double-blinded, randomized, placebo-controlled trial to investigate the effects of naldemedine on opioid-induced constipation for patients with cancer pain: A study protocol
por: Higashibata, Takahiro, et al.
Publicado: (2022)

Within-subject, double-blind, randomized, placebo-controlled evaluation of combining the cannabinoid dronabinol and the opioid hydromorphone in adults with chronic pain
por: Campbell, Claudia M., et al.
Publicado: (2023)

Evaluation of Risk Behavior in Gambling Addicted and Opioid Addicted Individuals
por: Gorzelańczyk, Edward J., et al.
Publicado: (2021)

Nicotine Free Herbal Composition for Smoking De-Addiction - A Placebo Controlled, Double Blind, Randomized, Multicentric Clinical Study
por: Tamoli, Sanjay Motilal, et al.
Publicado: (2023)

Opioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteria
por: Dennis, Brittany B., et al.
Publicado: (2015)

Effects of the peripherally acting μ-opioid receptor antagonist methylnaltrexone on acute pancreatitis severity: study protocol for a multicentre double-blind randomised placebo-controlled interventional trial, the PAMORA-AP trial
por: Knoph, Cecilie Siggaard, et al.
Publicado: (2021)

Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial
por: Muresanu, Dafin F., et al.
Publicado: (2016)

Effects of Golden Plaster on Knee Osteoarthritis: A Multicenter Randomized, Double-Blind, Placebo-Controlled Trial
por: Chen, Yan, et al.
Publicado: (2022)

Baclofen for maintenance treatment of opioid dependence: A randomized double-blind placebo-controlled clinical trial [ISRCTN32121581]
por: Assadi, Seyed Mohammad, et al.
Publicado: (2003)

Naloxegol to Prevent Constipation in ICU Adults Receiving Opioids: A Randomized Double-Blind Placebo-Controlled Pilot Trial
por: Duprey, Matthew S., et al.
Publicado: (2022)

308-nm Excimer Lamp vs. Combination of 308-nm Excimer Lamp and 10% Liquor Carbonis Detergens in Patients With Scalp Psoriasis: A Randomized, Single-Blinded, Controlled Trial
por: Rattanakaemakorn, Ploysyne, et al.
Publicado: (2021)

Effects of naftopidil on double-J stent-related discomfort: a multicenter, randomized, double-blinded, placebo-controlled study
por: Oh, Jong Jin, et al.
Publicado: (2017)

Alcohol Addiction and Chronic Alcoholism
por: Wikler, A.
Publicado: (1943)

Substitution treatment for opioid addicts in Germany
por: Michels, Ingo Ilja, et al.
Publicado: (2007)

The role of social isolation in opioid addiction
por: Christie, Nina C
Publicado: (2021)

How to prevent opioid abuse and addiction
por: Hwang, Sung Mi
Publicado: (2023)

A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease
por: Wun, Ted, et al.
Publicado: (2013)

Relapse prevention with levomilnacipran ER in adults with major depressive disorder: A multicenter, randomized, double‐blind, placebo‐controlled study
por: Durgam, Suresh, et al.
Publicado: (2019)

Serotonergic Neuroplasticity in Alcohol Addiction
por: Belmer, Arnauld, et al.
Publicado: (2016)

Effects of Pentoxifylline on Non-Alcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial in Iran
por: Baniasadi, Nadieh, et al.
Publicado: (2015)

Effects of acute alcohol ingestion on eye movements and cognition: A double-blind, placebo-controlled study
por: Silva, Jéssica Bruna Santana, et al.
Publicado: (2017)

Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial
por: Navarro, Victor J., et al.
Publicado: (2019)

Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial
por: An, Xuedong, et al.
Publicado: (2022)

Efficacy and Safety of Yokukansan in Treatment-Resistant Schizophrenia: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial
por: Miyaoka, Tsuyoshi, et al.
Publicado: (2015)

A Randomized, Double‐Blind, Placebo‐Controlled Multicenter Study of Adalimumab in Pediatric Patients With Enthesitis‐Related Arthritis
por: Burgos‐Vargas, Rubén, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rpgja7qnh51h6dj7apd1g6d7mj